Pages that link to "Q40453865"
Jump to navigation
Jump to search
The following pages link to Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. (Q40453865):
Displaying 50 items.
- Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia (Q26781526) (← links)
- Epigenetics advancing personalized nanomedicine in cancer therapy (Q27010637) (← links)
- DNMT3A Mutations in Acute Myeloid Leukemia (Q27559610) (← links)
- Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia (Q29394054) (← links)
- MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures (Q30432282) (← links)
- Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation (Q30441475) (← links)
- CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells (Q33301019) (← links)
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine (Q33841988) (← links)
- Leukaemogenesis: more than mutant genes (Q34275371) (← links)
- Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety (Q34557714) (← links)
- Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1. (Q34568861) (← links)
- Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia (Q34598109) (← links)
- Deregulated transcription factors in leukemia (Q34631474) (← links)
- Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages (Q35761469) (← links)
- Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer (Q35985483) (← links)
- RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis (Q36206674) (← links)
- PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia (Q36430688) (← links)
- Interindividual variability and co-regulation of DNA methylation differ among blood cell populations (Q36484141) (← links)
- Targeting epigenetic abnormalities with histone deacetylase inhibitors (Q36529933) (← links)
- Current therapeutic strategies for acute myeloid leukaemia (Q36539598) (← links)
- Gene silencing by DNA methylation in haematological malignancies (Q36816162) (← links)
- Cancer cell signaling pathways targeted by spice-derived nutraceuticals (Q36819371) (← links)
- DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication (Q36843784) (← links)
- Epigenetic regulation of normal and malignant hematopoiesis (Q36970179) (← links)
- Chromatin regulation by AML1 complex (Q37068800) (← links)
- Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date (Q37111794) (← links)
- Liquid chromatography mass spectrometry profiling of histones (Q37222851) (← links)
- Epigenetics in acute myeloid leukemia (Q37240566) (← links)
- Post-translational modifications of Runx1 regulate its activity in the cell (Q37455493) (← links)
- Novel targeted drug therapies for the treatment of childhood acute leukemia (Q37477482) (← links)
- Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503). (Q37558778) (← links)
- Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia (Q37622957) (← links)
- New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. (Q37679748) (← links)
- DNA Methylation Profiling in Acute Myeloid Leukemia: From Recent Technological Advances to Biological and Clinical Insights (Q37797467) (← links)
- Molecular diagnosis of acute myeloid leukemia (Q37809866) (← links)
- Epigenetics in AML (Q37815778) (← links)
- Epigenetic Mechanisms in Acute Myeloid Leukemia (Q37818094) (← links)
- Dynamics of epigenetic modifications in leukemia (Q37831766) (← links)
- Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects (Q37871413) (← links)
- Integrated analysis of genetic and epigenetic alterations in cancer (Q37962001) (← links)
- Origins of aberrant DNA methylation in acute myeloid leukemia (Q38130091) (← links)
- Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer (Q38150711) (← links)
- Aberrant epigenetic regulators control expansion of human CD34 hematopoietic stem/progenitor cells (Q38172135) (← links)
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders (Q38240733) (← links)
- A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease (Q38637596) (← links)
- On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver (Q38777440) (← links)
- Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia (Q38791735) (← links)
- Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. (Q39050008) (← links)
- Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia (Q39451939) (← links)
- Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells (Q40077017) (← links)